The Effect of Finasteride on Prostate Specific Antigen: Review of Available Data-Reference-Cited by-同舟云学术

The Effect of Finasteride on Prostate Specific Antigen: Review of Available Data

Published:1996-01 Issue:1 Volume:155 Page:3-9
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Guess Harry A.¹,Gormley Glenn J.¹,Stoner Elizabeth¹,Oesterling Joseph E.¹

Affiliation:

1. Merck Research Laboratories, Blue Bell, Pennsylvania and Rahway, New Jersey, and Department of Urology, University of Michigan, Ann Arbor, Michigan.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference33 articles.

1. The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group;Gormley;New Engl. J. Med.,1992

2. The effect of finasteride on prostate-specific antigen in men with benign prostatic hyperplasia;Guess;Prostate,1993

3. Effect of finasteride on serum PSA concentrations in men with benign prostatic hyperplasia. Results from the North American phase III clinical trial;Guess;Urol. Clin. N. Amer.,1993

4. Effect of finasteride on prostate-specific antigen density;Gormley;Urology,1994

5. Maintenance of clinical efficacy with finasteride therapy for 24 months in patients with benign prostatic hyperplasia. The Finasteride Study Group;Stoner;Arch. Intern. Med.,1994

Cited by 103 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The South African Prostate Cancer Screening Guidelines;South African Medical Journal;2024-05-09

2. Association between prediagnostic prostate‐specific antigen and prostate cancer probability in Black and non‐Hispanic White men;Cancer;2023-11-06

3. Treatment Algorithm for Management of Benign Prostatic Obstruction: An Overview of Current Techniques;Life;2023-10-18

4. A prospective evaluation of the effect of finasteride on prostate health index (phi);International Urology and Nephrology;2023-03-01

5. A machine learning approach to predict progression on active surveillance for prostate cancer;Urologic Oncology: Seminars and Original Investigations;2021-08